Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bio-E-Gel Phase 3 for Menopausal Symptoms
NCT00391417Phase 3Completed
- Sponsor
- BioSante Pharmaceuticals
- Start
- Sep 2003
01
Overview
Phase 3, randomised, double-blind trial of estradiol topical in hot flash and Vulvovaginal atrophy (VVA) (4 arms), sponsored by BioSante Pharmaceuticals. Primary endpoints: Mean change from baseline in number of daily moderate to severe hot flushes, Mean change from baseline in daily hot flush severity and 1 more. Started Sep 2003; status: completed.
02
Drugs
estradiol topical
03
Conditions
hot flashVulvovaginal atrophy (VVA)
Beyond the preview
Go deeper on NCT00391417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00391417.